- Home
- FSFG vs MIST Comparison
FSFG vs MIST Comparison
Compare FSFG & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSFG
- MIST
- Stock Information
- Founded
- FSFG 2008
- MIST 2003
- Country
- FSFG United States
- MIST Canada
- Employees
- FSFG N/A
- MIST N/A
- Industry
- FSFG Savings Institutions
- MIST Biotechnology: Pharmaceutical Preparations
- Sector
- FSFG Finance
- MIST Health Care
- Exchange
- FSFG Nasdaq
- MIST Nasdaq
- Market Cap
- FSFG 177.8M
- MIST 145.3M
- IPO Year
- FSFG 2008
- MIST N/A
- Fundamental
- Price
- FSFG $31.32
- MIST $2.00
- Analyst Decision
- FSFG Strong Buy
- MIST Strong Buy
- Analyst Count
- FSFG 3
- MIST 3
- Target Price
- FSFG $31.50
- MIST $6.33
- AVG Volume (30 Days)
- FSFG 36.4K
- MIST 1.3M
- Earning Date
- FSFG 10-23-2025
- MIST 11-11-2025
- Dividend Yield
- FSFG 2.03%
- MIST N/A
- EPS Growth
- FSFG 130.94
- MIST N/A
- EPS
- FSFG 3.10
- MIST N/A
- Revenue
- FSFG $79,674,000.00
- MIST N/A
- Revenue This Year
- FSFG N/A
- MIST N/A
- Revenue Next Year
- FSFG $7.37
- MIST N/A
- P/E Ratio
- FSFG $10.14
- MIST N/A
- Revenue Growth
- FSFG 10.53
- MIST N/A
- 52 Week Low
- FSFG $21.63
- MIST $0.63
- 52 Week High
- FSFG $33.00
- MIST $2.75
- Technical
- Relative Strength Index (RSI)
- FSFG N/A
- MIST 60.32
- Support Level
- FSFG N/A
- MIST $2.03
- Resistance Level
- FSFG N/A
- MIST $2.29
- Average True Range (ATR)
- FSFG 0.00
- MIST 0.09
- MACD
- FSFG 0.00
- MIST 0.00
- Stochastic Oscillator
- FSFG 0.00
- MIST 46.34
About FSFG First Savings Financial Group Inc.
First Savings Financial Group Inc provides various banking services to individuals and business customers in southern Indiana. The bank accepts deposits from the general public & uses those funds, along with other borrowings, mainly to originate a residential mortgage, commercial mortgage, construction, commercial business, & consumer loans, and to a lesser extent, to invest in mortgage-backed securities and other debt securities. The company conducts lending and deposit activities mainly with individuals and small businesses in its market area. The bank operates in two segments: core banking, which accounts for the majority of revenue, and SBA lending.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).